0001209191-17-041697.txt : 20170623
0001209191-17-041697.hdr.sgml : 20170623
20170623165745
ACCESSION NUMBER: 0001209191-17-041697
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170622
FILED AS OF DATE: 20170623
DATE AS OF CHANGE: 20170623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schroeder Theodore R
CENTRAL INDEX KEY: 0001378690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 17928250
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-22
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001378690
Schroeder Theodore R
6310 NANCY RIDGE DRIVE
SUITE 101
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (right to buy)
6.90
2017-06-22
4
A
0
11000
0.00
A
2027-06-21
Common Stock
11000
11000
D
The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2018 annual meeting of stockholders.
/s/ Marc Wilson, Attorney-in-Fact
2017-06-23